NeuroCytonix utilizes a protocol that combines magnetic fields and radiofrequency waves to stimulate neural pathways, promoting the regrowth of neurons and their connections in the brain. This technology targets neurological disorders such as cerebral palsy, stroke, and autism, aiming to restore lost brain function and improve the quality of life for affected individuals.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current treatments for neurological disorders like cerebral palsy, stroke, traumatic brain injury, vascular dementia, and autism often focus on managing symptoms rather than addressing the underlying brain damage. Traditional medical approaches may not effectively stimulate neural regeneration to restore lost brain function. This can leave individuals with limited options for recovery and improved quality of life.
Solution
NeuroCytonix offers a non-invasive protocol that combines magnetic fields and radiofrequency waves to stimulate neural pathways in the brain. This stimulation aims to promote the regrowth of neurons and the connections between them, addressing the root cause of neurological disorders. The NeuroCytonix protocol is designed to encourage the repair of damaged neurons and neural tracts, potentially restoring lost brain function. Clinical and imaging data suggest that the protocol can regrow the brain, representing a breakthrough in regenerative medicine.
Target Audience
The primary target audience includes individuals affected by neurological disorders such as cerebral palsy, stroke, traumatic brain injury, vascular dementia, and autism, as well as those suffering from neurological complications related to COVID-19.
Features
- Non-invasive treatment using a combination of magnetic fields and radiofrequency waves.
- Stimulation of specific signaling pathways within cells to encourage neural repair.
- Designed to promote the regrowth of neurons and neural connections (neural tracts).
- Protocol aims to restore lost brain function by addressing the underlying brain damage.
- Clinical data suggests potential for brain regrowth.
- Treatment protocols for cerebral palsy, stroke, traumatic brain injury, vascular dementia, autism, and neurological consequences of COVID-19.